Sanofi aligns itself with Google to streamline drug development
Technology is bleeding into healthcare, and big pharma is riding the wave. Sanofi $SNY appointed its first chief digital officer this February, following the footsteps of its peers. By May, the French drugmaker and some of its big pharma compatriots joined forces with Google parent Alphabet’s Verily unit to augment clinical trial research. On Tuesday, the Parisian company tied up with Google to access its cloud computing and artificial intelligence tech to spur the development of new therapies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.